R 1479
Alternative Names: R-1479; RO 1048297Latest Information Update: 27 Sep 2006
Price :
$50 *
At a glance
- Originator Argenta Discovery; Roche
- Developer Roche
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 27 Sep 2006 Discontinued - Phase-I for Hepatitis C treatment in United Kingdom (unspecified route)
- 27 Sep 2006 Discontinued - Phase-I for Hepatitis C treatment in USA (unspecified route)
- 27 Sep 2006 Discontinued as per oral presentation from Roche at the 232nd American Chemical Society National Meeting (232nd-ACS-2006,